Leap Therapeutics Inc 内部交易概览
暂无关于该公司的高管股东内部交易数据
暂无关于该公司18月以内的内部交易数据
Leap Therapeutics Inc 内部交易
Leap Therapeutics Inc 最新内部交易
Beigene, Ltd. | 10% Owner | 2021-09-24 | 买入 | 25,438 | 7,348,437 |
$28.5
|
-88.60%
|
Perceptive Life Sciences Master Fund Ltd | 10% Owner | 2020-06-22 | 买入 | 17,500 | 8,476,496 |
$20
|
-83.75%
|
Healthcare Ventures Ix, L.p. | 10% Owner | 2019-02-05 | 买入 | 5,714 | 4,144,804 |
$17.5
|
-81.43%
|
Christopher Mirabelli | CEO, President, Chairman, 10% Owner | 2019-02-05 | 买入 | 5,714 | 7,077,099 |
$17.5
|
-81.43%
|
Augustine Lawlor | COO, 10% Owner | 2019-02-05 | 买入 | 5,714 | 7,077,099 |
$17.5
|
-81.43%
|
Douglas E Onsi | CFO, GC, Treasurer & Secretary, 10% Owner | 2019-02-05 | 买入 | 5,714 | 4,458,693 |
$17.5
|
-81.43%
|
Augustine Lawlor | COO, 10% Owner | 2017-11-14 | 买入 | 10,578 | 6,535,671 |
$60.9
|
-94.66%
|
Christopher Mirabelli | CEO, President, COB, 10% Owner | 2017-11-14 | 买入 | 10,578 | 6,535,671 |
$60.9
|
-94.66%
|
Healthcare Ventures Ix, L.p. | 10% Owner | 2017-11-14 | 买入 | 10,578 | 3,573,376 |
$60.9
|
-94.66%
|
Douglas E Onsi | CFO, GC, Treasurer & Secretary, 10% Owner | 2017-11-14 | 买入 | 10,578 | 3,917,265 |
$60.9
|
-94.66%
|